
AVTE
Healthcare · Biotechnology · $77.7M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2025
EPS trend, 90 days to now · +38.9% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 26, 2025 | Time not confirmed | -9.80 | -6.65 | +32.1% |
| Nov 14, 2024 | Time not confirmed | -5.95 | -19.60 | -229.4% |
| Aug 12, 2024 | Before the open | -0.83 | -0.86 | -3.6% |
| May 13, 2024 | After the close | -0.76 | -0.83 | -9.2% |
| Mar 25, 2024 | After the close | -0.71 | -0.74 | -4.2% |
| Nov 13, 2023 | Before the open | -0.69 | -0.71 | -2.9% |
| Aug 14, 2023 | Before the open | -0.70 | -0.76 | -8.6% |
| May 15, 2023 | After the close | -0.60 | -0.67 | -11.7% |
| Mar 29, 2023 | After the close | -0.62 | -0.61 | +1.6% |
| Nov 14, 2022 | Before the open | -0.50 | -0.56 | -12.0% |
| Aug 15, 2022 | Before the open | -0.45 | -0.49 | -8.9% |
| May 16, 2022 | Before the open | -0.28 | -0.45 | -60.7% |
| Mar 30, 2022 | After the close | -0.31 |
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
| -0.35 |
| -12.9% |
| Nov 15, 2021 | Before the open | -0.26 | -0.26 | 0.0% |
| Aug 16, 2021 | Before the open | -0.16 | -23.80 | -14775.0% |
| Jun 30, 2021 | After the close | 0.00 | -12.77 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -3.70 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -1.91 | — |